TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

To assess the frequency of TP53 alterations and their correlation with other genetic changes and outcome in acute myeloid leukemia with complex karyotype (CK-AML), we performed integrative analysis using TP53 mutational screening and array-based genomic profiling in 234 CK-AML. TP53 mutations were f...

Full description

Saved in:
Bibliographic Details
Main Authors: Rücker, Frank Gert (Author) , Schlenk, Richard Friedrich (Author) , Bullinger, Lars (Author) , Zenz, Thorsten (Author) , Ganser, Arnold (Author) , Lichter, Peter (Author) , Döhner, Konstanze (Author) , Döhner, Hartmut (Author)
Format: Article (Journal)
Language:English
Published: March 2012
In: Blood
Year: 2012, Volume: 119, Issue: 9, Pages: 2114-2121
ISSN:1528-0020
DOI:10.1182/blood-2011-08-375758
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1182/blood-2011-08-375758
Verlag, kostenfrei, Volltext: http://www.bloodjournal.org/content/early/2011/12/20/blood-2011-08-375758
Get full text
Author Notes:Frank G. Rücker, Richard F. Schlenk, Lars Bullinger, Sabine Kayser, Veronica Teleanu, Helena Kett, Marianne Habdank, Carla-Maria Kugler, Karlheinz Holzmann, Verena I. Gaidzik, Peter Paschka, Gerhard Held, Marie von Lilienfeld-Toal, Michael Lübbert, Stefan Fröhling, Thorsten Zenz, Jürgen Krauter, Brigitte Schlegelberger, Arnold Ganser, Peter Lichter, Konstanze Döhner and Hartmut Döhner
Description
Summary:To assess the frequency of TP53 alterations and their correlation with other genetic changes and outcome in acute myeloid leukemia with complex karyotype (CK-AML), we performed integrative analysis using TP53 mutational screening and array-based genomic profiling in 234 CK-AML. TP53 mutations were found in 141/234 (60%) and TP53 losses were identified in 94/234 (40%) CK-AML; in total, 164/234 (70%) cases had TP53 alterations. TP53-altered CK-AML were characterized by a higher degree of genomic complexity (aberrations per case, 14.30 vs. 6.16; P<.0001), and by a higher frequency of specific copy number alterations, such as -5/5q-, -7/7q-, -16/16q-, -18/18q-, +1/+1p, and +11/+11q/amp11q13~25; among CK-AML, TP53-altered more frequently exhibited a monosomal karyotype (MK). Patients with TP53 alterations were older and had significantly lower complete remission rates, inferior event-free, relapse-free, and overall survival. In multivariable analysis for overall survival, TP53 alterations, white blood cell counts, and age were the only significant factors. In conclusion, TP53 is the most frequently known altered gene in CK-AML. TP53 alterations are associated with older age, genomic complexity, specific DNA copy number alterations, MK, and dismal outcome. In multivariable analysis, TP53 alteration is the most important prognostic factor in CK-AML, outweighing all other variables, including the MK category.
Item Description:Prepublished online as Blood First Edition paper, December 20, 2011; DOI 10.1182/blood-2011-08-375758
Gesehen am 08.05.2018
Physical Description:Online Resource
ISSN:1528-0020
DOI:10.1182/blood-2011-08-375758